Combining IORT With Chemotherapy Improves Survival in Pancreatic Cancer

Newsfeed Image, Light Gray Text On Dark Gray Background
Pancreatic cancer remains a dreaded disease, with a little less than half the patients presenting with locally advanced, usually unresectable, disease. Even with neoadjuvant chemotherapy, survival remains dismal.

A new study conducted at Massachusetts General Hospital (MGH) evaluated the impact of intraoperative radiotherapy (IORT), along with induction chemotherapy and chemo-radiotherapy, in patients with advanced disease, and observed hints of success. Read more . . .